BlackRock Fund Advisors’s PLx Pharma PLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$26K Buy
2,052
+85
+4% +$3.12K ﹤0.01% 3856
2016
Q3
$228K Buy
1,967
+8
+0.4% +$780 ﹤0.01% 3408
2016
Q2
$155K Buy
1,959
+321
+20% +$27.8K ﹤0.01% 3549
2016
Q1
$125K Sell
1,638
-107
-6% -$6.8K ﹤0.01% 3601
2015
Q4
$156K Buy
+1,745
New +$167K ﹤0.01% 3621

Other funds holding PLXP

BlackRock Fund Advisors's PLXP Position: Q4 2016 in Review

BlackRock Fund Advisors increased its PLx Pharma (PLXP) stake by 4.3% in Q4 2016, buying an estimated $3.12K and bringing the position to 2,052 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #3856.

BlackRock Fund Advisors first reported a position in PLXP in Q4 2015 and has held it in 5 quarters since. The position peaked at $228K in Q3 2016. 19 funds tracked by Wall St. Rank hold PLXP as of Q4 2016.

  • BlackRock Fund Advisors held 2,052 shares of PLx Pharma worth $26K as of Q4 2016.
  • BlackRock Fund Advisors bought 85 PLx Pharma shares in Q4 2016, an estimated $3.12K.
  • PLx Pharma made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3856 holding.
  • BlackRock Fund Advisors first reported a position in PLx Pharma in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Fund Advisors's PLx Pharma position peaked at $228K in Q3 2016.
  • 19 funds tracked by Wall St. Rank held PLx Pharma as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.